Abstract
Severe spasticity of spinal origin has been proven to be a good indication for intrathecal baclofen (ITB) infusion. ITB is nondestructive, reversible, and can be titrated precisely, allowing retention of extant function while diminishing spasticity. It is also associated with few complications. In our hospital, a patient with spinal cord injury underwent implantation using a programmable pump and intrathecal catheter designed to deliver baclofen directly to the spinal cord. Rigidity (tone) decreased from a mean prebolus Ashworth score of 3.75 to a mean postbolus Ashworth score of 2.13. But during the course, the pump was removed due to MRSA infection, which resulted in reoccurrence of severe spasticity although the infection healed. Reimplantation was carried out due to the patients continuous request. Ashworth scores reduced to an acceptable level after reimplantation.Intrathecal therapy showed a statistically significant improvement of tone and spasms, and seems to be an effective treatment for patients with severe spasticity.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
